Table 1.
Sociodemographics of the patient populations (SS and TAS) and epilepsy disease characteristics at baseline T1
| Demographics | SS | TAS |
|---|---|---|
| n = 235 | n = 166 | |
| Age (y) | ||
| Mean | 15.6 | 14.77 |
| Range | 0‐78 | 0‐63 |
| Age group, n (%) | ||
| 0‐4 | 63 (26.8) | 46 (27.7) |
| 5‐9 | 36 (15.3) | 29 (17.5) |
| 10‐19 | 64 (27.2) | 42 (25.3) |
| 20‐39 | 55 (23.4) | 39 (23.5) |
| ≥40 | 16 (6.8) | 10 (6.0) |
| Sex, n (%) | ||
| Male | 132 (56.2) | 93 (56) |
| Female | 103 (43.8) | 73 (44) |
| Health insurance status, n (%) | ||
| Social health care | 164 (69.8) | 120 (72.3) |
| Private insurance | 42 (17.9) | 28 (16.9) |
| Not insured | 12 (5.1) | 6 (3.6) |
| Unknown | 17 (7.2) | 12 (7.2) |
| Setting, n (%) | ||
| Rural | 152 (64.7) | 107 (64.5) |
| Urban (Kigali) | 78 (33.2) | 59 (35.5) |
| Abroad | 5 (2.1) | 0 (0) |
| Seizure type, n (%) | ||
| Generalized tonic‐clonica | 189 (80.4) | 131 (78.9) |
| Focal aware motor/non‐motor | 11 (4.7) | 20 (12.0) |
| Focal impaired awareness motor/non‐motor | 2 (0.9) | 3 (1.8) |
| Focal to bilateral tonic‐clonic | 19 (8.1) | 1 (0.6) |
| Not classified | 14 (6.0) | 10 (6.0) |
| Alternative treatment use (reported >1%), n (%) | ||
| Never used for epilepsy | 158 (67.2) | 102 (61.4) |
| Prayers | 10 (4.3) | 38 (22.9) |
| Herbal medicine | 16 (6.8) | 12 (7.2) |
| Missing data | 51 (21.7) | 11 (6.6) |
SS, safety set at study start T1; TAS, total analysis set at follow‐up T2.
a
Due to limited diagnostic resources, seizure type requires cautious interpretation; generalized tonic‐clonic may include focal onset, generalized onset, and unknown origin.